Salim Yusuf Selected Research

Ramipril (Altace)

1/2021	Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk.
1/2021	Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke.
1/2021	Polypill with or without Aspirin in Persons without Cardiovascular Disease.
10/2020	Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials.
1/2020	Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.
1/2020	Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries.
1/2018	Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
11/2017	Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients.
6/2017	Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
1/2017	Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salim Yusuf Research Topics

Disease

179	Stroke (Strokes) 12/2022 - 01/2002
123	Heart Failure 10/2022 - 01/2002
113	Myocardial Infarction 12/2022 - 01/2002
113	Hemorrhage 11/2022 - 02/2003
112	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 01/2002
99	Atrial Fibrillation 01/2022 - 07/2002
46	Hypertension (High Blood Pressure) 07/2022 - 01/2002
39	Acute Coronary Syndrome 11/2019 - 09/2002
34	Vascular Diseases (Vascular Disease) 10/2022 - 03/2002
32	Embolism (Embolus) 04/2021 - 09/2009
29	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 01/2002
27	Ischemic Stroke 05/2022 - 09/2008
24	Peripheral Arterial Disease 12/2022 - 07/2007
21	Thrombosis (Thrombus) 06/2022 - 02/2003
21	Diabetes Mellitus 01/2020 - 03/2002
21	Unstable Angina 01/2018 - 09/2002
19	Atherosclerosis 01/2022 - 01/2002
19	ST Elevation Myocardial Infarction 01/2018 - 01/2005
16	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2003
16	Left Ventricular Dysfunction 03/2014 - 01/2002
14	Hypotension (Low Blood Pressure) 10/2022 - 09/2003
14	Ischemia 12/2020 - 12/2004
13	Abdominal Obesity 01/2022 - 01/2003
12	Neoplasms (Cancer) 01/2022 - 10/2004
11	Coronary Disease (Coronary Heart Disease) 12/2017 - 09/2003
11	Albuminuria 07/2016 - 03/2003
11	Glucose Intolerance 07/2014 - 02/2003
10	Cognitive Dysfunction 06/2022 - 10/2008
10	Obesity 01/2022 - 04/2007
9	Chronic Renal Insufficiency 12/2021 - 04/2007
9	Hyperkalemia 12/2014 - 01/2002
8	Heart Arrest (Cardiac Arrest) 01/2021 - 09/2004
8	Insulin Resistance 01/2018 - 01/2002
7	Infections 02/2022 - 05/2014
7	Renal Insufficiency (Renal Failure) 01/2020 - 01/2002
6	Infarction (Infarctions) 10/2020 - 11/2005
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 09/2008
5	Hemorrhagic Stroke 01/2022 - 09/2009

Drug/Important Bio-Agent (IBA)

89	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 04/2002
63	candesartanIBA 10/2022 - 09/2003
56	Ramipril (Altace)FDA LinkGeneric 01/2021 - 01/2002
52	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022 - 01/2002
45	Telmisartan (Micardis)FDA Link 01/2021 - 01/2002
44	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 09/2009
42	Dabigatran FDA Link 01/2020 - 09/2009
36	Clopidogrel (Plavix)FDA Link 11/2021 - 09/2002
33	RivaroxabanIBA 12/2022 - 01/2017
33	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 02/2003
30	AnticoagulantsIBA 11/2021 - 02/2003
29	CreatinineIBA 01/2022 - 01/2002
29	Angiotensin Receptor AntagonistsIBA 12/2017 - 10/2004
27	LipidsIBA 10/2022 - 09/2004
25	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2005
23	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019 - 01/2002
21	Vitamin K FDA Link 04/2021 - 05/2009
20	Pharmaceutical PreparationsIBA 10/2022 - 01/2002
19	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 12/2009
18	SodiumIBA 09/2021 - 11/2011
17	Fondaparinux (Arixtra)FDA Link 05/2014 - 03/2005
16	apixabanIBA 04/2021 - 03/2010
16	Insulin (Novolin)FDA Link 01/2019 - 12/2004
14	CholesterolIBA 11/2022 - 07/2007
13	ApolipoproteinsIBA 05/2022 - 09/2004
12	Irbesartan FDA LinkGeneric 01/2020 - 11/2007
11	omega-Chloroacetophenone (Mace)IBA 10/2022 - 05/2014
11	PotassiumIBA 01/2021 - 12/2004
11	Insulin Glargine (Lantus)FDA Link 01/2019 - 01/2008
11	Heparin (Liquaemin)FDA LinkGeneric 05/2014 - 02/2003
10	Rosuvastatin Calcium (Crestor)FDA Link 01/2022 - 01/2015
9	Apolipoproteins B (ApoB)IBA 05/2022 - 09/2004
9	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 09/2011
9	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 09/2005
9	Enalapril FDA LinkGeneric 03/2014 - 12/2002
8	Lipoproteins (Lipoprotein)IBA 05/2022 - 07/2008
8	Troponin T (Troponin T1)IBA 01/2022 - 01/2011
8	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 07/2006
8	HDL CholesterolIBA 01/2022 - 07/2003
8	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2021 - 05/2016
8	Enoxaparin (Lovenox)FDA LinkGeneric 05/2011 - 12/2005
7	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2005
6	AlbuminsIBA 01/2021 - 12/2006
6	LDL CholesterolIBA 01/2020 - 05/2016
6	Factor Xa InhibitorsIBA 01/2018 - 03/2005
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2016 - 12/2002
6	HomocysteineIBA 02/2012 - 01/2002
5	C-Reactive ProteinIBA 01/2022 - 07/2006
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 07/2003
5	ORALIT (ORS)IBA 10/2019 - 11/2005
5	Digoxin (Digitek)FDA LinkGeneric 10/2019 - 12/2002

Therapy/Procedure

136	Therapeutics 10/2022 - 01/2002
28	Percutaneous Coronary Intervention 01/2020 - 02/2003
20	Secondary Prevention 11/2020 - 03/2002
12	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2022 - 11/2003
8	Surgical Amputation (Amputations) 01/2022 - 11/2013
7	Long-Term Care 10/2019 - 04/2012
7	Stents 01/2018 - 09/2010
6	Length of Stay 01/2020 - 07/2002
6	Thrombectomy 01/2018 - 03/2014
6	Drug Therapy (Chemotherapy) 01/2018 - 02/2010
5	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2020 - 03/2013